Substituted pyrazoles

Details Substituted pyrazoles Substituted pyrazoles

2007-09-04

2007-09-04

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S320000, C514S406000, C514S407000

Reexamination Certificate

active

11147923

ABSTRACT:
Substituted pyrazoles of general formulamethods of manufacturing them, compositions containing them, and methods of using them to, for example, treat autoimmune diseases mediated by cathepsin S, and inhibit cathepsin S activity, are described.

REFERENCES:
patent: 4500525 (1985-02-01), Winters et al.
patent: 5264676 (1993-11-01), Shutske et al.
patent: 5739153 (1998-04-01), Peignier et al.
patent: 5776718 (1998-07-01), Palmer et al.
patent: 5856514 (1999-01-01), Peignier et al.
patent: 5976858 (1999-11-01), Palmer et al.
patent: 6030946 (2000-02-01), Klaus et al.
patent: 6287840 (2002-09-01), Palmer et al.
patent: 6949540 (2005-09-01), Cai et al.
patent: 0254241 (1988-01-01), None
patent: 382637 (1993-07-01), None
patent: 502786 (1996-04-01), None
patent: 655248 (1999-09-01), None
patent: 1489280 (1977-10-01), None
patent: 50116470 (1975-09-01), None
patent: 52014765 (1977-02-01), None
patent: WO 94/29276 (1994-12-01), None
patent: WO 95/23222 (1995-08-01), None
patent: WO 96/30353 (1996-10-01), None
patent: WO 97/21439 (1997-06-01), None
patent: WO 97/40066 (1997-10-01), None
patent: WO 98/52940 (1998-11-01), None
patent: WO 9856785 (1998-12-01), None
patent: WO 99/24460 (1999-05-01), None
patent: WO 99/48911 (1999-09-01), None
patent: WO 99/58153 (1999-11-01), None
patent: WO 00/49008 (2000-08-01), None
patent: WO 00/51998 (2000-09-01), None
patent: WO 00/55144 (2000-09-01), None
patent: WO 01/09110 (2001-02-01), None
patent: WO 01/19796 (2001-03-01), None
patent: WO 01/40204 (2001-06-01), None
Palmer, J.T. et al. Vinyl Sulfones as Mechanism-Based Cystein Protease Inhibitors, J. Med. Chem. 1995, 38(17), 3193-3196.
Bromme, D. et al., “Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors,” Biochem. J. 1996, 315, 85-89.
McGrath, M.E. et al., “Crystal structure of human cathepsin S,” Protein Sci. 1998. 7(6), 1294-1302.
Nerenberg, J.B. et al., “Design and Synthesis of N-Alkylated Saccharins as Selective a-1A Adrenergic Receptor Antagonist,” Boorg. Med. Chem. Lett. 1998, 8, 2467-2472.
Honey, K. et al., “Role of Lysosomal Cysteine Proteinases in Antigen Presentation on CD4 T Cells,” Inflammation Research 2001, Supp. 3, 50, S159, abstr. Oct./2001.
Li, W. et al., “Tissue Specific Expression of Cathepsins and Antigen Presentation,” Inflammation Research, 2001, Supp. 3, 50, S159, abstr. Oct./2002.
Magill, C. et al., “Cysteine Proteases in Antigen Presenation and Models of Inflammation,” Inflammation Research 2001, Supp. 3, 50, S159, abstr. Oct./2003.
Allen, E.M. et al, “Reversible Cathepsin S (CATS) Inhibitors Block Invariant Chain Degradation Both In Vitro and In Vivo,” Inflammation Research 2001, Supp. 3, 50, S159, abstr. Oct./2004.
Podolin, P.L. et al., “Inhibition of Cathepsin S Blocks Invariant Chain Processing and Antigen-Induced Proliferation in Vitro, and Reduces the Severity of Collagen-Induced Arthritis In Vivo,” Inflammation Research 2001, Supp. 3, 50, S159, abstr. Oct./2005.
Spero, D. et al., “Design and Synthesis of Novel Cathepsin S Inhibitors,” Inflammation Research 2001, Supp. 3, 50, S206, abstr. 079.
Andronati, S.A. et al., “Synthesis of 1-(4-(4-phenyl-1-piperazinyl)butyl 1,2-dihydro-3H-1,4-benzodiazepin-2-ones and 1H-indazoles and their affinity for benzodiazepine receptors,” Chemical Abstracts Number (CAN) 122:314528 (1994) 8:126-131.
Bromme, D. et al., “High level expression and crystallization of recombinant human cathepsin S,” Protein Sci. 1996, 5, 789-791.
Kirschke, H. et al., “Cathepsin S,” Handbook of Proteolytic Enzymes; Barrett, A.J.; Rawlings, N.D.; Woessner, J.F., Editors, Academic Press (1998) 621-624.
Nakagawa, T.Y. et al., “Impaired Invariant Chain Degradation and Antigen Presentation and Diminished Collagaen-Induced Arthritis in Cathepssin S Null Mice,” Immunity 1999, 10, 207-217.
Riese, R.J. et al., “Cathepsin S Activity Regulates Antigen Presentation and Immunity,” J. Clin. Invest. 1998, 101(11), 2351-2363.
Shi, G.P. et al., “Cathepsin S Required for Normal MHC Class II Peptide Loading and Germinal Center Development,” Immunity 1999, 10, 197-206.
Singh, P. et al., “Quantitative Structure-Activity Relationship Studies on a New Class of Antihypertensive Agents: Derivatives of 3-Aryl-4,5,6,7-tetrahydro-1H-pyrazolo [4,3-c] pyridine,” Quant. Struct. -Act. Relat. 1990, 9, 29-32.
Winters, G. et al., “Synthesis, in Vitro [3H] Prazosin Displacement, and in Vivo Activity of 3-Aryl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines, a New Class of Antihypertensive Agents,” J. Med. Chem. 1985, 28(7), 934-940.
Andronati, “Synthesis of 3-aryl-1-[4-phenyl-1-piperazinyl)butyl] iondazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors,” Pharmazie 1999, 54(2), 99-101.
Fujimura, Y. et al. “Indazole derivatives”, Database CA Online, Chemical Abstracts Service, STN database accession no. 87:53281, XP002193796abstract(Feb. 3, 1977) relating toJP 52014765(Chugai Pharmaceutical Co., Ltd.).
Fujimura, Y. et al. “Indazole derivatives.” Database CA Online, Chemical Abstracts Service, STN database accession no. 84:59450, XP002193797abstract(Sep. 11, 1975) relating toJP 50116470(Chugai Pharmaceutical Co., Ltd.).
Nakatsuka, M. et al. “Preparation of pyrazole derivatives as immunosuppressants.” Database CA Online, Chemical Abstracts Service, STN database accession no. 130:52417, XP002193692abstract(Dec. 17, 1998) relating toWO9856785(Sumitomo Pharmaceuticals Co., Ltd.).
Saegusa, K. et al. Cathepsin S Inhibitor Prevents Autoantigen Presentation and Autoimmunity. J. Clin. Invest. 2002, 110(3), 361-369.

Affiliated with

Also associated with

Rating

Substituted pyrazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted pyrazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3728294